Article Information
History
- June 30, 2017.
Article Versions
- You are currently viewing Version 1 of this article (June 30, 2017 - 10:03).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Claudia Fredolini‡,
- Sanna Byström‡,
- Laura Sanchez-Rivera‡,
- Marina Ioannou‡,
- Davide Tamburro¥,
- Rui M. Branca¥,
- Janne Lehtiö¥,
- Peter Nilsson‡ and
- Jochen M. Schwenk‡,*
- ‡Affinity Proteomics, Science for Life Laboratory, School of Biotechnology, KTH – Royal Institute of Technology, Box 1031, SE-171 21 Solna, Sweden
- ¥Cancer Proteomics, Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institute, Box 1031, SE-171 21 Solna, Sweden
- ↵*Corresponding author: Jochen M Schwenk, Affinity Proteomics, Science for Life Laboratory, School of Biotechnology, KTH – Royal Institute of Technology, Box 1031, 171 21 Solna, Sweden, E: jochen.schwenk{at}scilifelab.se; T: +46 (0)8 790 9869